MAPK3 and breast carcinoma: Moreover, our results obtained in functional in vitro model suggest, that CHI3L2 is involved in IDC basal B breast cancer cells, represent in our studies by BT-549 cells, in modulation of ERK1/2 and STAT-3 phosphorylation patchways.